
Mild ovarian stimulation has emerged as an alternative to conventional IVF with the advantages of being more patient-friendly and less expensive. Inadequate data on pregnancy outcomes and concerns about the cycle cancellation rate (CCR) have prevented mild, or low-dose, IVF from gaining wide acceptance.OBJECTIVE AND RATIONALETo evaluate parallel-group randomised controlled trials (RCTs) on IVF...
Like
Save
Share